HTR7 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P34969 |
---|---|
Clone Names | 100430127 |
Gene ID | 3363 |
---|---|
Other Names | 5-hydroxytryptamine receptor 7, 5-HT-7, 5-HT7, 5-HT-X, Serotonin receptor 7, HTR7 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | HTR7 |
---|---|
Function | This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase. |
Cellular Location | Cell membrane; Multi-pass membrane protein. |
Tissue Location | Isoform A is the predominant isoform in spleen, caudate and hippocampus. Isoform B is expressed at lower levels Isoform D is a minor isoform in terms of expression |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The neurotransmitter, serotonin, is thought to play a rolein various cognitive and behavioral functions. The serotoninreceptor encoded by this gene belongs to the superfamily of Gprotein-coupled receptors and the gene is a candidate locus forinvolvement in autistic disorder and other neuropsychiatricdisorders. Three splice variants have been identified which encodeproteins that differ in the length of their carboxy terminal ends.
References
Ruano, G., et al. Pharmacogenomics 11(7):959-971(2010)Pinheiro, A.P., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (5), 1070-1080 (2010) :Corominas, R., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (1), 177-184 (2010) :Wei, Z., et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33(3):547-551(2009)Iceta, R., et al. J. Physiol. Pharmacol. 60(1):157-164(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.